Active substancePancreatinPancreatin
Similar drugsTo uncover
  • Gastenorm forte
    pills inwards 
  • Gastenorm forte 10000
    pills inwards 
  • Creon® 10000
    capsules inwards 
  • Creon® 25000
    capsules inwards 
  • Creon® 40000
    capsules inwards 
  • Creon® Micro
    granules inwards 
  • Mezim® 20000
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Mezim® forte
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Mezim® forte 10000
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Micrazim®
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Micrazim®
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Pangrol® 25000
    capsules inwards 
  • PanziKam
    pills inwards 
    CAMELIA NPP, LLC     Russia
  • Panzim® forte
    pills inwards 
    BRYNTSALOV-A, CJSC     Russia
  • Pancreatic
    pills inwards 
    TECHNOLOG, JSC     Ukraine
  • Pancreatin
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Pancreatin
    pills inwards 
  • Pancreatin
    pills inwards 
    AVEKSIMA, JSC     Russia
  • Pancreatin
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Pancreatin
    pills inwards 
    FARMPROJECT, CJSC     Russia
  • Pancreatin
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pancreatin forte
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pancreatin-LekT
    pills inwards 
  • Penzital
    pills inwards 
  • Enzistal®-P
    pills inwards 
  • Hermitage®
    capsules inwards 
  • Dosage form: & nbspcoated tablets
    Composition:

    In 1 tablet, coated with a shell, contains:

    Core:

    Pancreatin with a minimal:

    lipolytic activity - 3 500 units Ph.Eur.

    amylolytic activity - 4 200 units Ph.Eur.

    total proteolytic activity - 250 units Ph.Eur.

    Excipients:

    Microcrystalline cellulose - 98.140 mg, carboxymethyl starch sodium salt (type A) - 12,500 mg, silicon dioxide colloid - 4,000 mg, magnesium stearate - 0.750 mg.

    Sheath: Talc 2.243 mg, hypromellose 2.243 mg, azorubin lacquer (E 122) 0.076 mg, simethicone emulsion 30% (dry weight) 0.005 mg, polyacrylate dispersion 30% (dry weight) 1.495 mg, titanium dioxide (E 171) - 2,243 mg, macrogol 6000 - 0,872 mg.

    Description:

    Pink flat-coated tablets, covered with a shell, with almost plane-parallel surfaces and bevelled edges, with a characteristic odor of pancreatin.

    Pharmacotherapeutic group:digestive enzyme.
    ATX: & nbsp

    A.09.A.A   Enzyme preparations

    A.09.A.A.02   Pancreatin

    Pharmacodynamics:

    The drug compensates for the lack of exocrine function of the pancreas.

    The pancreatin enzymes of lipase, amylase and protease facilitate the digestion of fats, carbohydrates and proteins, which contributes to their fuller absorption in the small intestine.

    Indications:

    - Insufficiency of the exocrine function of the pancreas,

    (chronic pancreatitis, cystic fibrosis, etc.)

    - Chronic inflammatory - dystrophic diseases of the stomach, intestines, liver, gall bladder. Conditions after resection or irradiation of these organs, accompanied by disruption of food digestion, flatulence, diarrhea (as part of combination therapy).

    - To improve the digestion of food in patients with normal function of the gastrointestinal tract in the case of errors in nutrition.

    - Preparation for X-ray and ultrasound examination of the abdominal organs.

    Contraindications:

    Hypersensitivity to the components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis.

    Pregnancy and lactation:

    The safety of pancreatin in pregnancy is not well understood.The application is possible in cases where the expected benefit for the mother exceeds the potential risk to the fetus.

    Dosing and Administration:

    The dose is determined individually depending on the degree of digestion disorders. Adults: 1 - 2 tablets before meals, without chewing and washing with water.

    If necessary, in addition, take 1-4 tablets during meals.

    In children, the drug is used as directed by a doctor.

    Duration of treatment can vary from several days (if the digestive process is disturbed due to errors in the diet) to several months or years (if necessary, permanent replacement therapy).

    Side effects:

    Allergic reactions, diarrhea or constipation, nausea, discomfort in the epigastric region. With prolonged use in high doses, it is possible to develop hyperuricosuria, an increase in the level of uric acid in the blood plasma.

    In single cases in patients suffering from cystic fibrosis, stricture in the ileocecal region is observed after taking high doses.

    Interaction:

    With the simultaneous use of pancreatin with iron preparations, it is possible to reduce absorption of the latter.Simultaneous use of antacid agents containing calcium carbonate and / or magnesium hydroxide can lead to a decrease in the effectiveness of pancreatin.

    Form release / dosage:

    The tablets covered with a cover.

    Packaging:

    For 20 tablets in a blister of PVC film / aluminum foil.

    For 1, 2, 4 or 5 blisters with instructions for use in a cardboard box.

    Storage conditions:Store at a temperature not exceeding 25 ° C.
    Keep out of the reach of children!
    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N013391 / 01
    Date of registration:06.04.2007
    The owner of the registration certificate:BERLIN-PHARMA, CJSC BERLIN-PHARMA, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.08.2015
    Illustrated instructions
      Instructions
      Up